SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 170 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q1 2017. The put-call ratio across all filers is 1.82 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $0 | -100.0% | 16,074 | -95.0% | 0.00% | – |
| Q4 2018 | $36,000 | -90.4% | 318,791 | +44.0% | 0.00% | -100.0% |
| Q3 2018 | $376,000 | -9.0% | 221,343 | -6.8% | 0.00% | 0.0% |
| Q2 2018 | $413,000 | +1.5% | 237,518 | +6.7% | 0.00% | 0.0% |
| Q1 2018 | $407,000 | -16.1% | 222,673 | +2.3% | 0.00% | 0.0% |
| Q4 2017 | $485,000 | -35.5% | 217,593 | -16.1% | 0.00% | -50.0% |
| Q3 2017 | $752,000 | -34.0% | 259,408 | +1.4% | 0.00% | -33.3% |
| Q2 2017 | $1,139,000 | +10.6% | 255,918 | +15.8% | 0.00% | +50.0% |
| Q1 2017 | $1,030,000 | -15.4% | 220,976 | +10.4% | 0.00% | -33.3% |
| Q4 2016 | $1,218,000 | +21.3% | 200,076 | +9.8% | 0.00% | 0.0% |
| Q3 2016 | $1,004,000 | +58.9% | 182,229 | +9.5% | 0.00% | +50.0% |
| Q2 2016 | $632,000 | +135.8% | 166,429 | +71.3% | 0.00% | +100.0% |
| Q1 2016 | $268,000 | -50.7% | 97,164 | +1.3% | 0.00% | -50.0% |
| Q4 2015 | $544,000 | +15.5% | 95,874 | +7.9% | 0.00% | 0.0% |
| Q3 2015 | $471,000 | -33.8% | 88,869 | +3.8% | 0.00% | 0.0% |
| Q2 2015 | $711,000 | +59.8% | 85,633 | -11.0% | 0.00% | +100.0% |
| Q1 2015 | $445,000 | +85.4% | 96,238 | +22.5% | 0.00% | 0.0% |
| Q4 2014 | $240,000 | +13.2% | 78,538 | +3.0% | 0.00% | 0.0% |
| Q3 2014 | $212,000 | -27.6% | 76,263 | +5.8% | 0.00% | 0.0% |
| Q2 2014 | $293,000 | -18.4% | 72,063 | +6.7% | 0.00% | 0.0% |
| Q1 2014 | $359,000 | -10.7% | 67,559 | -5.5% | 0.00% | 0.0% |
| Q4 2013 | $402,000 | +21.8% | 71,479 | -1.0% | 0.00% | 0.0% |
| Q3 2013 | $330,000 | +5.4% | 72,179 | -0.5% | 0.00% | 0.0% |
| Q2 2013 | $313,000 | – | 72,520 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|